Sally Beauty (S7V) AI Stock Analysis

0 Followers

Sally Beauty

(BX Swiss:S7V)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Debt reduction and cash generationStronger cash generation and the elimination of reported debt materially improve financial flexibility. This gives Sally Beauty more capacity to fund stores, digital initiatives and product expansion internally, while reducing financing costs and balance-sheet risk over the next several quarters.

Negative Factors

Historically weak revenue growthThe multi-year period of limited top-line growth shows that recent acceleration follows a prolonged demand and mix challenge. If the improvement does not persist, Sally Beauty may have less operating leverage and fewer resources to support investment in its longer-term growth initiatives.

Sally Beauty Business Overview & Revenue Model

Company Description

Sally Beauty Holdings, Inc. functions as a specialized vendor and distributor of professional beauty products. The company’s operations are divided into two main business units: Sally Beauty Supply and Beauty Systems Group. The Sally Beauty Supply di...

Sally Beauty Earnings Call Summary

Earnings Call Date:Nov 10, 2026(Q4-2026)|Next Earnings Date:Feb 04, 2027

Earnings Call SentimentPositive

The call was predominantly positive. Management reported fiscal 2026 sales and earnings growth, sustained positive Sally comparable sales, strong digital and category momentum, significant cash generation, completed cost savings, shareholder returns and a detailed fiscal 2027 growth plan. The main challenges were declines in care, a still-negative BSG comparable-sales trend, gross-margin pressure, inflationary costs, promotional activity and inconsistent add-on services. Highlights significantly outweighed the lowlights.

Positive Updates

Strong Fiscal 2026 Full-Year Results

Fiscal 2026 net sales reached $3.73 billion, adjusted operating margin was 9%, adjusted diluted EPS increased 9.5% to $2.08, and cash flow from operations exceeded $300 million; the CFO later reported cash flow from operations of $323 million.

Negative Updates

Care Category Decline at Sally

The Sally care category declined 7% in the fourth quarter. Management attributed the pressure primarily to owned brands, the planned fiscal 2027 relaunch of the Ion care line and short-term supply challenges affecting a handful of SKUs.

Company Guidance

For fiscal 2027, the company expects consolidated net sales in the range of $3.77 billion to $3.81 billion, comparable sales growth of 1% to 2%, adjusted operating earnings in the range of $334 million to $347 million, adjusted diluted earnings of $2.20 to $2.30 per share, 50% of free cash flow deployed to share repurchases, capital expenditures of approximately $140 million and free cash flow of approximately $200 million; for the first quarter, it expects consolidated net sales in the range of $945 million to $955 million, including approximately 30 basis points of unfavorable impact from foreign currency rates, comparable sales growth of 0.5% to 1.5%, adjusted operating earnings in the range of $75 million to $80 million and adjusted diluted earnings of $0.48 to $0.52 per share. Sally will likely grow a bit faster than BSG, while BSG is expected to return to growth this year; plans call for approximately 100 new Sally Ignited locations, accelerating towards 180 stores by year-end, with the opportunity to scale beyond fiscal 2027 in the range of 200 locations annually and convert up to 1,500 locations or 2/3 of the Sally U.S. fleet.

Sally Beauty Risk Analysis

Sally Beauty disclosed 34 risk factors in its most recent earnings report. Sally Beauty reported the most risks in the "Ability to Sell" category.

Ability to Sell - Risks related to the company’s ability to sell goods and services

Latest Risks Added

0 New Risks

Sally Beauty Peers Comparison

Overall Rating

UnderperformOutperform

Sector (61)

Financial Indicators

CH:S7V against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
FIVE	74Outperform	$13.96B	22.33	27.73%	―	25.56%	126.16%
ULTA	72Outperform	$28.41B	23.92	45.40%	―	11.16%	5.20%
BBWI	66Neutral	$4.37B	5.79	-61.76%	3.68%	-2.18%	14.77%
Sector *	61Neutral	$18.38B	12.79	-2.54%	3.03%	1.52%	-15.83%
RVLV	59Neutral	$1.42B	21.63	12.37%	―	14.69%	18.66%
MNSO	58Neutral	$3.41B	19.27	14.11%	6.07%	30.43%	-44.33%

* Consumer Cyclical Sector Average

Performance Comparison

CH:S7V and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
BBWI	Bath & Body Works, Inc.	21.72	0.64	3.06%
ULTA	Ulta Beauty	659.08	125.21	23.45%
FIVE	Five Below Inc	250.74	103.68	70.50%
RVLV	Revolve Group	19.90	-1.40	-6.57%
MNSO	Miniso Group Holding Ltd.	10.98	-9.81	-47.19%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Sally Beauty AI Stock Analysis